Thrombocytopenia (short version)
Compliance rules
1Summary
A deficiency of platelets results from a reduced production in the bone marrow (formation disorder) or from an increased loss (consumption disorder). The patient's risk is largely determined by the extent of thrombocytopenia (platelet count), its duration, the respective disease etiology, and other patient-specific factors (e.g., age-related vascular fragility, comorbidity, or anticoagulant medication). For prognosis, a rapid diagnosis with recording of the pathogenesis is crucial, as effective treatments are available for most thrombocytopenias, which can significantly reduce the morbidity and mortality of thrombocytopenia and/or its underlying systemic disease.
2Therapy
The current treatment algorithm is depicted in Figure 1.
3[Kapitel nicht relevant]
4[Kapitel nicht relevant]
5[Kapitel nicht relevant]
6[Kapitel nicht relevant]
7[Kapitel nicht relevant]
8[Kapitel nicht relevant]
9[Kapitel nicht relevant]
10Active studies
11Systemic Therapy – Protocols
12Study results
13Certification Status
14Links
16Disclosures
Conflicts of interest can be found in the full German version of the guideline.
Download
Reference:
Quellenangabe:
Onkopedia-Leitlinien werden kontinuierlich an den Stand des Wissens angepasst. Die jeweils gültige Version, AGB und Nutzungsbedingungen finden Sie unter www.onkopedia.com.
Für die kommerzielle Nutzung wenden Sie sich bitte an onkopedia@dgho.de.
Onkopedia guidelines are continuously adapted to the state of knowledge. The currently valid version, terms of use and general terms and conditions can be found at onkopedia-guidelines.info.
For commercial use, please contact onkopedia@dgho.de.
